Penumbra Inc
Penumbra is a U.S.-based medical device company focused on thrombectomy and related interventional therapies for removing blood clots from the body. Its portfolio spans products used in ischemic stroke, pulmonary embolism, acute limb ischemia, embolization, and vascular access, and it sells through direct commercial teams and distributors across the United States and international markets.
Fiscal year 2025 · change from previous year
Development 2020–2025
Business
Share of revenueDevices and systems used to remove blood clots in stroke, PE, and limb ischemia.
Products used by specialists treating ischemic stroke and other neurovascular conditions.
Tools for accessing vessels and treating vascular abnormalities or bleeding.
Adjunct products and newer offerings supporting the broader interventional portfolio.
Products
Reported · share of revenue- Thrombectomy67.5 %
- Embolization32.5 %
Source: 10-K FY2025, revenue the company reports per product line (SEC XBRL). Shares are of the lines shown and add up to 100 %.
Customers
Penumbra sells primarily to hospitals and healthcare systems that perform high-acuity interventional procedures. The end users are specialist physicians such as interventional neuroradiologists, neurosurgeons, interventional neurologists, interventional radiologists, interventional cardiologists, and vascular surgeons who choose these devices based on clinical performance, ease of use, and workflow efficiency.
Buy devices for use in acute care and interventional suites where clot removal procedures are performed.
Interventional neuroradiologists, neurologists, radiologists, cardiologists, and surgeons who use the products in procedures.
Buy and resell products in select markets where Penumbra does not sell entirely through direct teams.
Providers adopting thrombectomy and embolization therapies as clinical evidence and training expand.
Strategy
Penumbra’s strategy centers on expanding its thrombectomy and interventional portfolio through product development, clinical evidence, and commercial expansion. It also continues to invest in manufacturing capacity, inventory, and international reach so it can support broader adoption of its devices and launch new products across target end markets.
New and improved devices support adoption in stroke, PE, and limb ischemia.
Specialist physicians need proof of efficacy and training before changing practice.
Device demand requires reliable production, inventory, and facility footprint.
Broader geographic reach diversifies demand and extends the installed base.
Geography
Q1/2026Penumbra generates most of its revenue in the United States, with the balance coming from international markets. It sells directly in the U.S., most of Europe, Canada, Australia, and Singapore, and uses distributors in select countries, so its operating footprint is tied to both hospital adoption and regulatory access across multiple healthcare systems.
Share of the revenue the company reports by geography.
Risks
Penumbra faces competitive, regulatory, and execution risks typical of medical device companies, including reimbursement pressure, product adoption hurdles, and dependence on specialist physicians. Company-specific risks include supplier concentration, IT and ERP disruption, and uncertainty around the proposed Boston Scientific acquisition, all of which could affect operations and customer continuity.
- Supplier concentration and component shortagesImpact: HighLikelihood: Medium
Many materials and components come from a limited number of suppliers, with little guaranteed supply.
Exposure: Manufacturing continuity and product availability
- Reimbursement and pricing pressureImpact: HighLikelihood: Medium
Hospitals and payors may limit payment for medical devices through cost-control programs.
Exposure: Procedure adoption and realized selling prices
- Competitive intensityImpact: HighLikelihood: Medium
Large rivals have broader product lines, deeper relationships, and more resources.
Exposure: Market share and physician adoption
- Acquisition uncertaintyImpact: HighLikelihood: Medium
Pending transaction uncertainty can affect customers, employees, and business execution.
Exposure: Commercial continuity and strategic flexibility
- IT and ERP implementation disruptionImpact: MediumLikelihood: Medium
System changes can interrupt order tracking, shipping, supply chain, and financial data aggregation.
Exposure: Operations and reporting reliability
Accounting
Judgemental itemsDevice revenue depends on shipment timing, returns, and contract terms.
Impact: Can shift quarterly revenue and comparability
Production planning and inventory levels affect cost of sales and obsolescence risk.
Impact: Affects gross margin and working capital
The company recorded charges when exiting immersive healthcare.
Impact: Can materially affect operating income in the period recognized
System implementations can affect order tracking and financial data aggregation.
Impact: May influence cut-off, controls, and reporting reliability
Similar listed companies
Publicly listed companies with a comparable business focus.
LivaNova PLC
LIVN · Electromedical & Electrotherapeutic Apparatus
LivaNova PLC is a medical technology company focused on therapies for cardiac and neurological conditions.
Boston Scientific Corporation
BSX · Surgical & Medical Instruments & Apparatus
Boston Scientific Corporation develops, manufactures, and markets medical devices used across a wide range of interventional specialties.
Globus Medical, Inc
GMED · Surgical & Medical Instruments & Apparatus
Globus Medical is a U.S.-based medical device company focused on musculoskeletal care, with products used in spine, orthopedic trauma, hip, knee, extremity and neurosurgical procedures.
enVVeno Medical Corp
NVNO · Surgical & Medical Instruments & Apparatus
enVVeno Medical Corp is a U.S.-based medical device company focused on developing bioprosthetic venous valve technologies for severe chronic venous insufficiency.
TriSalus Life Sciences, Inc.
TLSIW · Surgical & Medical Instruments & Apparatus
TriSalus Life Sciences is a U.S.-based medical device company focused on catheter-based infusion systems used in interventional oncology procedures.
ENvue Medical, Inc.
FEED · Orthopedic, Prosthetic & Surgical Appliances & Supplies
Last updated: 24/09/2026